Moderna Wins Regulatory Reversal as U.S. FDA Agrees to Evaluate New Shot
- Posted on February 19, 2026
- By International Business Times
- 4 Views
Moderna Wins Regulatory Reversal as U.S. FDA Agrees to Evaluate New Shot
Moderna wins FDA reversal as regulators agree to review its new mRNA flu vaccine for potential 2026 approval.
